Providing Quality HIV Care
The Latest
Transgender People Must Be Included in Every Aspect of HIV Research
Descovy’s approval for PrEP showcases real-life ramifications of leaving trans people out of research. But including trans people is about more than just saying trans people are welcome, says researcher Brian Minalga.
This Week in HIV Research: More Answers—and Questions—on Cannabis Use
Jan. 23, 2020: Neurocognitive benefits of cannabis use; how unquantifiable HIV in CSF correlates to executive function; updated findings on efavirenz and microcephaly; cost-efficacy of a specialized HIV care coordination team.
This Week in HIV Research: Just a Text Away
Jan. 16, 2020: Texting (and stigma support) vs. email for care retention; beyond-childhood health risks for HIV-exposed infants; HIV, cardiovascular risk, and cognitive impairment; direct-acting antiviral efficacy and prescription delays.
How One Nurse Practitioner Builds Relationships to Boost HIV Suppression
“I’m not a physician. … We can diagnose and treat, but fundamentally we are taught to care.”
Despite ART, Immune System Ages Faster Among People Living With HIV, Study Finds
Even with an undetectable viral load, study participants who had been vaccinated as children lost smallpox immunity.
New York City Makes Strides in HIV Diagnosis Times, More Work Ahead
Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
This Week in HIV Research: A New Year, an Old Enemy
Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
This Week in HIV Research: Where Our Reach Falls Short
Dec. 19, 2019: Often-insufficient CD4 and viral load testing for women; factors affecting syphilis incidence among women with HIV; STI testing rates among people with HIV; the effect of benzodiazepines on neurocognition.
This Community-Based Hepatitis C Treatment-Incentive Program Shows Great Results
The HIV services organization Housing Works implemented a hepatitis C treatment program in New York City, with very high completion rates.
Pick Your Topic
Featured Collections
HIV Spotlight Center: Caring for the Newly Diagnosed Patient
Information, news, and perspectives aimed at helping the health care workforce provide effective care and services for people who have been recently diagnosed with HIV.
This Week in HIV Research
We scan peer-reviewed journals and summarize recently published HIV-related manuscripts with the potential to affect clinical care and services. To beat HIV, you have to follow the science!
Meet the Experts
Paul E. Sax, M.D.
Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.
David Alain Wohl, M.D.
David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.